The University of Chicago Hospitals – Trademark Portfolio

Entity Type: 99

The University of Chicago Hospitals holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. Currently, 1 trademark is registered. Notable registered marks include THE UNIVERSITY OF CHICAGO COMER CHILDREN'S HOSPITAL. The owner is based in Chicago, IL.

MC 1110 5841 S Maryland

Chicago, IL 606371470

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

The University of Chicago Hospitals's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does The University of Chicago Hospitals have?

The University of Chicago Hospitals has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.

What trademark classes does The University of Chicago Hospitals file in?

The University of Chicago Hospitals files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are The University of Chicago Hospitals's most well-known trademarks?

The University of Chicago Hospitals's registered trademark portfolio includes well-known marks such as THE UNIVERSITY OF CHICAGO COMER CHILDREN'S HOSPITAL. These are among 1 currently registered trademark in the portfolio.

What is The University of Chicago Hospitals's trademark registration success rate?

The University of Chicago Hospitals has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.